title: Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?
authors.affiliation: Department of Internal Medicine, the Xingtan Affiliated Hospital of the First People's Hospital of Shunde, Foshan 528300, China.
authors.forename: Lin
authors.initials: L
authors.lastname: Xiao
authors.affiliation: Department of Cardiology, the First People's Hospital of Shunde, Foshan 528300, China.
authors.forename: Haichun
authors.initials: H
authors.lastname: Ouyang
authors.affiliation: Department of Internal Medicine, the Xingtan Affiliated Hospital of the First People's Hospital of Shunde, Foshan 528300, China.
authors.forename: Qiwen
authors.initials: Q
authors.lastname: Su
authors.affiliation: Department of Cardiology, the First People's Hospital of Shunde, Foshan 528300, China. Electronic address: hyuli821@163.com.
authors.forename: Yuli
authors.initials: Y
authors.lastname: Huang
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors
keywords: Angiotensin II receptor blockers; Angiotensin-converting enzyme inhibitors; Hypertension; Stroke